Panbela Therapeutics EV/EBIT
What is the EV/EBIT of Panbela Therapeutics?
The EV/EBIT of Panbela Therapeutics Inc. is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Panbela Therapeutics
What does Panbela Therapeutics do?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Companies with ev/ebit similar to Panbela Therapeutics
- Radha Madhav has EV/EBIT of N/A
- Acasti Pharma Inc has EV/EBIT of N/A
- Akers Biosciences Inc has EV/EBIT of N/A
- Agios Pharmaceuticals Inc has EV/EBIT of N/A
- Generation Bio Co has EV/EBIT of N/A
- Purple Biotech has EV/EBIT of N/A
- Panbela Therapeutics has EV/EBIT of N/A
- Continental Materials has EV/EBIT of N/A
- GlycoMimetics Inc has EV/EBIT of N/A
- Veritas Pharma has EV/EBIT of N/A
- Impac Mortgage has EV/EBIT of N/A
- Canterra Minerals has EV/EBIT of N/A
- Kinnate Biopharma has EV/EBIT of N/A